Table 2.
Epidemiological summary of symptomatic surveillance showing prevalence and overall burden from confirmed targets found in SNF 1 and SNF 2
| Positive target detected | Prevalence (%) | Estimated number of annual casesa | |
|---|---|---|---|
| SNF1 | 7 | 23.3 | 28 |
| Para 3 | 4 | 13.3 | 16 |
| Rhino/Entero | 3 | 10.0 | 12 |
| SNF2 | 3 | 16.6 | 12 |
| Flu B | 1 | 5.5 | 4 |
| Rhino/Entero | 1 | 5.5 | 4 |
| RSV | 1 | 5.5 | 4 |
Assuming period prevalence is sustained during a 12-month period.